Other languages NovaBay Pharmaceuticals

Equities

NBY

US66987P3001

Market Closed - Nyse Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
0.077 ^USD	-0.39%		-8.33%	-62.25%

Mar. 26	Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024
Mar. 26	NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26
NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 26
New Age Investments LLC completed the acquisition of DERMAdoctor, Inc. from NovaBay Pharmaceuticals, Inc..	Mar. 24
NovaBay Pharmaceuticals, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Fiscal Year 2023	Mar. 14
NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals	Mar. 13
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma?s Extensive Distributor Network	Jan. 09
NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Novabay Pharmaceuticals, Inc. Announces Commercial Launch of Avenova Allograft	23-09-14
NovaBay to Commercialize BioStem's Amniotic Tissue Allograft	23-09-11
NovaBay Pharmaceuticals, Inc. Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova®? Allograft	23-09-11
NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Novabay Pharmaceuticals, Inc. Announces Audrey Kunin to Retire and Resign from Her Position as Chief Product Officer Effective as of November 5, 2023	23-07-06
Novabay Pharmaceuticals, Inc. Approves to Elect Mijia Wu as Director	23-06-14
NovaBay Pharmaceuticals, Inc. Announces DERMAdoctor's KP Duty Lotion and Scrub Ultra Duo Set for Dry, Rough, Bumpy Skin to Be Featured on QVC at a Special Price	23-06-12
Wall Street Set to Open Higher; Investors Look to Powell Speech for Fed Action Hints	23-05-19
US Futures Trend Higher Pre-Bell Ahead of Powell Speech	23-05-19
Top Premarket Gainers	23-05-19
NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
NovaBay Pharmaceuticals Gets $1 Million Order for NeutroPhase	23-05-01
Novabay Pharmaceuticals, Inc. Fulfills $1 Million Order for Neutrophase Skin and Wound Cleanser for China Pioneer Pharma Holdings	23-05-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NovaBay Pharmaceuticals

Equities

NBY

US66987P3001

Other languages

Filters